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Abstract
Aims/hypothesis According to the thrifty genotype hypoth-
esis, the high prevalence of type 2 diabetes and obesity is a
consequence of genetic variants that have undergone
positive selection during historical periods of erratic food
supply. The recent expansion in the number of validated
type 2 diabetes- and obesity-susceptibility loci, coupled
with access to empirical data, enables us to look for
evidence in support (or otherwise) of the thrifty genotype
hypothesis using proven loci.
Methods We employed a range of tests to obtain comple-
mentary views of the evidence for selection: we determined
whether the risk allele at associated ‘index’ single-nucleotide
polymorphisms is derived or ancestral, calculated the
integrated haplotype score (iHS) and assessed the population
differentiation statistic fixation index (FST) for 17 type 2
diabetes and 13 obesity loci.
Results We found no evidence for significant differences
for the derived/ancestral allele test. None of the studied loci
showed strong evidence for selection based on the iHS
score. We find a high FST for rs7901695 at TCF7L2, the
largest type 2 diabetes effect size found to date.
Conclusions/interpretation Our results provide some evi-
dence for selection at specific loci, but there are no consistent
patterns of selection that provide conclusive confirmation of
the thrifty genotype hypothesis. Discovery of more signals
and more causal variants for type 2 diabetes and obesity is
likely to allow more detailed examination of these issues.
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Abbreviations
CEU Centre d’Etude du Polymorphisme Humain (CEPH)
(Utah residents with northern and western European
ancestry)
CHB Han Chinese in Beijing, China
FST Population differentiation statistics (fixation index)
iHS Integrated haplotype score
JPT Japanese in Tokyo
SNP Single nucleotide polymorphism
YRI Yoruba in Ibadan, Nigeria
Introduction
Type 2 diabetes and obesity are complex traits, caused by
multiple environmental and genetic factors. In recent
decades, there has been a dramatic rise in the prevalence
of type 2 diabetes and obesity in the Western and
developing world. Adaptation to powerful selective forces
for genotypes that provide survival advantage has been
proposed as an explanation for this observed capacity of a
genetic disease to become so prevalent when unmasked by
changes in environment. In 1962, James Neel suggested
that exposure to periods of famine during human evolu-
tionary history resulted in selection pressures in favour of a
thrifty genotype that led to highly efficient fat storage
during periods of abundance [1]. In the current climate of
food overabundance and sedentary lifestyle, this thrifty
genotype is suggested to lead to metabolically disadvanta-
geous phenotypes.
Signals of positive selection resulting in reduced
haplotype diversity can be identified by investigating
haplotype structure and allelic architecture. For example,
if the thrifty genotype hypothesis were true, we would
expect to observe some of the following characteristics at
disease loci: risk alleles would be derived alleles; there
would be substantial differences in allele frequency across
different populations; and there would be evidence that
relatively recently emerging alleles have been swept to high
frequency. These tests offer the possibility of detecting
selection signals, operating over different time scales
(ranging from recent positive selection identified through
extreme integrated haplotype scores [iHSs] to the much
older time frame of derived/ancestral allele status), and we
would therefore not expect to obtain consistent evidence
across the different tests.
The fields of type 2 diabetes and obesity genetics had
until recent years met with limited success in identifying
replicating loci. The advent of large-scale, well-designed
association studies, coupled with large-scale follow-up and
stringent criteria for declaring reproducible association, has
led to the identification of well-established type 2 diabetes
and obesity loci. This enables us for the first time to carry
out a systematic examination of these genomic loci for
evidence of signatures of selection, and thereby seek to
corroborate or refute the thrifty genotype hypothesis.
Methods
For the purposes of this study, we define a confirmed type 2
diabetes or obesity locus as one that has been robustly
replicated, reaching a genome-wide significance threshold
of p<5×10−8. This criterion yields 17 loci for type 2
diabetes (in or near the TCF7L2, PPARG, KCNJ11,
CDKAL1, SLC30A8, IGF2BP2, NOTCH2, THADA, JAZF1,
CDC123/CAMK1D , TSPAN8/LGR5 , HHEX/IDE ,
CDKN2A/B, ADAMTS9, TCF2, WFS1 and KCNQ1 genes)
[2] and 13 for obesity (associations with BMI) (in or near
the FTO, TMEM18, MC4R, GNPDA2, SH2B1, KCTD15,
MTCH2, NEGR1, PCSK1, LGR4/LIN7C/BDNF [two inde-
pendent single nucleotide polymorphisms {SNPs}], ETV5/
SFRS10/DGKG and MAF genes) [3–8] (Tables 1 and 2).
We have selected a representative (index) SNP for each of
these 30 independently associated loci and have examined
several characteristics of the genomic sequence that might
indicate evidence for selection.
First, we determined whether the risk allele at the index
SNPs is the ancestral or derived allele, using information
available through dbSNP build 128 (www.ncbi.nlm.nih.
gov/SNP/, accessed February 2009), based on chimpanzee/
human sequence alignment.
We also calculated population differentiation statistics
(fixation index FST) for the 30 loci in the three HapMap
phase II populations: Centre d’Etude du Polymorphisme
Humain (CEPH) (Utah residents with northern and western
European ancestry) (CEU); Yoruba in Ibadan, Nigeria
(YRI); and Japanese in Tokyo (JPT)+Han Chinese in
Beijing, China (CHB) [9]. FST measures the proportion of
total genetic variance that is caused by differences between
two or more population samples. Local selection acting on
a given locus can result in elevated FST values between two
populations. We can identify loci that have unusually high
FST values by comparing against the rest of the genome,
which provides an empirical null distribution. The use of an
empirical FST distribution in this case is advantageous,
because it does not require assumptions about the structure
of human populations, SNP ascertainment bias (which
differs among the three HapMap population samples) and
differences in local linkage disequilibrium patterns among
different populations. We constructed an empirical FST
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distribution using over 2.9 million SNPs, or the subset of all
HapMap Phase II SNPs with genotype data available in all
the three reference samples (HapMap Release 22, April 2007).
We compared the observed FST values for the obesity and
type 2 diabetes loci with the upper 95% tail of the distribution
to obtain a one-tailed test for diversifying selection.
We additionally investigated evidence for natural selec-
tion by examining the iHS, a measure of recent positive
selection for variants that have not yet reached fixation [10,
11]. This statistic identifies SNPs for which alleles have
rapidly changed in frequency by comparing the haplotype
background of the ancestral and derived alleles. Negative
iHS values indicate that the derived allele resides on a
longer haplotype, whereas positive iHS values suggest that
the ancestral allele resides on a longer haplotype. For the
purposes of this study, we define iHS <−1.5 and iHS >1.5
as suggestive evidence for natural selection, and iHS scores
<−2 or >2 as evidence for a powerful selection signal [10].
We determined the iHS score for each locus in HapMap
phase II data using Haplotter (http://hg-wen.uchicago.edu/
selection/haplotter.htm, accessed February 2009) [10, 11].
Results
Evidence that type 2 diabetes- or obesity-associated risk
alleles were more often derived than ancestral would be
consistent with positive selection. In type 2 diabetes, we
found the risk allele to be the derived allele at six of the 17
loci (CDC123/CAMK1D, TSPAN8/LGR5, NOTCH2,
CDKN2A/B, IGF2BP2 and KCNJ11) (binomial test one-
sided p=0.93) (Table 1). Similarly, we did not observe a
significant overrepresentation of derived status for the
obesity-risk alleles (seven [MC4R, GNPDA2, MTCH2,
NEGR1, PCSK1, LGR4/LIN7C/BDNF and ETV5/SFRS10/
DGKG], p=0.50) (Table 2). Among the type 2 diabetes
loci, ten risk alleles are major and seven minor (binomial
test two-sided p=0.63) (Table 1). Among the obesity-risk
alleles, six are major and seven are minor (p=1.00)
(Table 2).
Only one locus (rs7901695 at TCF7L2) showed an
elevated FST value of 0.579 (2.1 percentile), between the
JPT + CHB and YRI sample (previously also noted [12]),
and in the comparison between CEU and JPT+CHB (FST=
0.323, 5.2 percentile) (Table 1). SNP rs5215 at KCNJ11
demonstrated an elevated FST value of 0.384 between CEU
and YRI (5.9 percentile) (Table 1).
Among the type 2 diabetes-associated loci, the NOTCH2
rs10923931 index SNP demonstrated an elevated iHS value
(2.249, 2.3 percentile) for the protective, ancestral allele
(Table 1). Among the BMI-associated SNPs, the strongest
signal of positive selection was obtained for the FTO locus,
with an iHS value of 1.991 (4.4 percentile) (Table 2). No
general enrichment for high FST or long haplotypes was
observed for the set of diabetes- or obesity-associated SNPs
(using Mann–Whitney significance testing).
Discussion
We have not observed significant evidence for overrepre-
sentation of ancestral/derived status or for minor/major
frequency at type 2 diabetes- or obesity-risk alleles. Only
one locus (at the type 2 diabetes TCF7L2 locus) demon-
strates large allele frequency differences across populations.
Although this is consistent with chance, we note that
TCF7L2 represents the strongest effect size to be identified
in type 2 diabetes to date and, as such, may have been more
susceptible to selection forces. Notably, we did not find
strong evidence for high differentiation of rs2237892 at
KCNQ1 between the European and East Asian sample
(FST=0.209, 13.3 percentile of the empirical distribution).
The risk allele C at this locus has frequencies close to 90%
in the CEU and YRI HapMap samples and close to 60% in
the two East Asian samples.
Our analyses indicate the presence of extended haplo-
types at the FTO locus, the largest effect size for obesity
found to date. However, we have not identified any
consistent footprint of selection across the loci that would
support the notion of a universal mechanism to explain the
high prevalence of type 2 diabetes and obesity. The number
of robustly replicating type 2 diabetes and obesity loci
identified is poised to grow, offering the promise of an
extended established disease locus list. In addition, expan-
sion of association studies to populations of non-European
descent is likely to broaden the spectrum of robustly
associated allelic variation and may help identify loci with
prominent evidence for population differentiation, for
example where risk alleles at a SNP have rapidly changed
in frequency since population separation. Importantly, the
truly causal, functional variants for the majority, if not all,
of established type 2 diabetes- and obesity-susceptibility
loci have not been determined yet. We have therefore been
restricted to studying index SNPs, representative of the
replicating associations, which could have an effect on the
variant-specific analyses we have carried out, as these may
provide only indirect glimpses of the history of the causal
mutations.
This study has been exhaustive in terms of comprehen-
sively considering all known, well-established type 2
diabetes- and BMI-susceptibility variants. Some loci appear
to have more ‘thrifty gene’ characteristics than others, but
there is no clear globally consistent transpiring picture.
Further emerging insights into the genetic aetiology of
these complex traits are likely to help us distinguish
between apparent and real signals for positive selection.
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